Posted on

cbd oil mast cell stabilizer


While there is no cure for MCAS, there is a lot you can do to minimise the condition’s impact on your life. The good news is that most of the natural treatments for MCAS are recommendations for a healthier life that anyone would benefit from. To read more about living with MCAS, check out 12 Tips for Living With Mast Cell Activation Syndrome.

To reduce histamine levels in your body, you should adopt a low histamine diet. Avoid the following:

2. Increasing Histamine Breakdown

The condition may be mild in some people and only exacerbate in response to a significant life stressor, which may be either physical or psychological in nature (divorce, bankruptcy, loss of job, travel, infection, death of a loved one, exposure to novel infections, occupying a water damaged building, exposure to cold or heat). In others, symptoms may develop from a young age and slowly become worse over time. People with MCAS are likely to experience a few of the most common symptoms. Because mast cells are located throughout the body, symptoms can affect the eyes, nose, ears, throat, skin, heart, blood, lungs, gastrointestinal tract and the nervous, endocrine and musculoskeletal systems.

Other things to consider in MCAS patients:

With a chronic illness such as MCAS, it is possible to live a full life—the treatment just requires a careful, comprehensive approach. If you believe you have MCAS or have already received a diagnosis and need a functional medical doctor who specialises in MCAS in Calgary, Alberta, you can request an appointment here or call 403-206-2333.

Both quercetin and green tea extracts may inhibit the COMT enzyme. If you have a COMT ++ enzyme (slow function) on your 23andme, be careful when using these two supplements. The COMT gene determines your ability to process catechols, oestrogen and the major neurotransmitters adrenaline, noradrenaline and dopamine. Your anxiety, insomnia and pain may increase due to further slowing down of the excretion of these excitatory chemicals plus the excitatory catechols, substances found in green and black tea, coffee, chocolate, green coffee-bean extracts and quercetin.

Naïve mice have small numbers (<5%) of CD11b + Gr-1 + cells in peripheral tissues such as spleen, whereas 18% to as high as 50% in the bone marrow (28, 32, 33). As CBD induces robust accumulation of MDSC rapidly in the peritoneum by 6–12 hours, we speculated that the cells may be migrating from bone marrow. To test this, we injected WT mice with CBD and analyzed for CD11b + Gr-1 + cells at 0 and 12 h in bone marrow and peritoneum ( Fig. 4A ). Corresponding with the significant accumulation of MDSC in the peritoneum, we observed a significant decrease in the frequency of CD11b + Gr-1 + cells in the bone marrow 12 h following exposure to CBD. This indicated that CD11b + Gr-1 + cells were migrating from bone marrow in response to CBD. Further, CBD-induced MDSC from peritoneum showed expression of immature myeloid marker CD31 and were found to be actively dividing based on positive Ki-67 staining ( Fig. 4B ). These results suggested that CBD-induced MDSCs from peritoneum are immature, actively proliferating myeloid cells, directly derived from BM myeloid precursors rather than reprogrammed, terminally differentiated myeloid population.

A) Time-course of CD11b + Gr-1 + cell accumulation in WT peritoneum following CBD (20 mg/kg, i.p.) administration. Representative dot plots from FACS analysis are shown for the time points as indicated. B) Absolute number of MDSC calculated from frequency of CD11b + Gr-1 + cells and total viable cells in each peritoneum, mean ± SD (n=4). C) Representative dot plots from FACS analysis of cells harvested from peritonea of WT mice (n=4) 16 h after injecting with various doses of CBD as indicated showing dose-dependent induction of CD11b + Gr-1 + double positive cells. D) Mean±SD of absolute MDSC numbers from n=4 mice per group. E, F) Induction of CD11b + Gr-1 + cells by CBD is independent of TLR4. TLR4-mutant C3H/HeJ mice (n=4) injected with vehicle or 20 mg/kg CBD (i.p.). After 12 h peritoneal exudate cells were analyzed by FACS. Error bars indicate SD. Student’s t-test: *P<0.05, **P<0.01 compared vs control.

We analyzed the chemokine response to CBD in the peritoneum to identify the important chemokine mediators associated with the induction of MDSC. G-CSF and GM-CSF have been previously shown to play important roles in the development and induction of MDSC (34, 35). We analyzed these chemokines in the peritoneal exudates at various time points following the administration of CBD by ELISA. G-CSF levels were markedly increased in response to CBD as early as 6 h, peaking around 12 h and starting to decrease by 48 h ( Fig. 7A ). We did not see any change in the levels of GM-CSF. We also determined other potential chemokines, M-CSF and KC (CXCL1) in peritoneal exudates post-CBD injection. We observed significant induction of M-CSF at 12 and 24 h ( Fig. 7B ) and a sharp induction of CXCL1 at 12 h ( Fig. 7C ) in response to CBD. These data suggested that G-CSF, CXCL1 and M-CSF may play a role in the induction of MDSC by CBD in vivo.


62%). After 24 hours of transfection, cells were treated with vehicle (control), CBD or a positive control PPARγ agonist, troglitazone. For in vitro assays the vehicle for CBD contained <0.1% DMSO at final concentrations. Luciferase assay was performed 24 hours following treatment using a commercially available Dual-Glo® luciferase assay system (Promega) and measured in a luminometer (Perkin Elmer). Values were expressed as normalized relative luciferase units and fold induction compared to control was calculated.

Multiple pathways have been shown to be responsible for MDSC-mediated T cell suppression (11, 12, 41, 52). Production of Arg1 enzyme appears to be one of the most crucial mechanisms as both granulocytic and monocytic subsets of MDSC are known to express Arg1. Arg1 acts by metabolizing L-arginine, an essential amino acid needed for T cell proliferation and survival, thus inhibiting T cell proliferation. We observed that CBD-induced MDSC expressed functional Arg1. In addition, T cell suppressive activity of CBD-induced MDSC was significantly attenuated in the presence of a specific arginase inhibitor.

Adoptive transfer of mast cells in mast cell-deficient mice

In the current study, therefore, we investigated if administration of CBD into normal mice would induce MDSC. Interestingly, we found that CBD caused robust induction of immunosuppressive CD11b + Gr-1 + MDSC in naïve mice which was associated with significant upregulation of G-CSF, M-CSF and CXCL1. We demonstrate that this response is dependent on mast cells, and primarily mediated by PPARγ.